Paronychia is a soft tissue infection around a fingernail. Paronychia occurs in 2 forms: acute and chronic. The etiology, infectious agent, and treatment are usually different for each form, and the 2 forms are often considered separate entities.
Mechanism
Paronychia, whether acute or chronic, results from a breakdown of the protective barrier between the nail and the nail fold. The entry of organisms into the moist nail crevice results in the bacterial or fungal (yeast or mold) colonization of the area.
The anatomy of the nail complex is shown in the image below. The nail is longitudinally flanked by 2 lateral folds or perionychium. Proximally, it is covered by the eponychium. Distal to the perionychium, the region immediately beneath the free edge of the nail is the hyponychium. The hyponychium serves as a tough physical barrier that resists bacterial infection.
The nail or nail plate lies immediately on top of the nail bed, which consists of 2 portions involved in the production, migration, and maintenance of the nail. The proximal portion, called the germinal matrix, contains active cells that are responsible for generating new nail. Damage to the germinal matrix results in malformed nails. The distal portion, the sterile matrix, adds thickness, bulk, and strength to the nail. The white crescent-shaped opacity at the proximal end of the nail is the lunula, which is the visible portion of the germinal matrix. The whiteness of the lunula is due to the poor vascularity of the germinal matrix. The nail arises from a mild proximal depression called the nail fold. The nail divides the nail fold into 2 components: the dorsal roof and the ventral floor, both of which contain germinal matrices. The skin overlying the nail fold is called the nail wall.
The nail bed receives its blood supply from the 2 terminal branches of the volar digital artery. A fine network in the proximal nail bed and in the skin proximal to the nail fold of the finger provides venous drainage. Lymphatic drainage follows a course similar to that of the venous network. The lymphatic network is dense in the nail bed, especially in the hyponychium. Innervation is derived from the trifurcation of the dorsal branch of the volar digital nerve. One branch goes to the nail fold, one to the pulp, and one to the distal tip of the finger.
The patient’s history is crucial in determining the possibility of more serious underlying systemic conditions that may predispose the patient to paronychia. These underlying conditions may include diabetes, obesity, hyperhidrosis, immunologic defects, polyendocrinopathy, and drug-induced immunosuppression. Note the following:
Acute paronychia physical findings are as follows:
Chronic paronychia physical findings are as follows:
Acute paronychia causes are as follows:
Chronic paronychia causes are as follows:
Other conditions associated with abnormalities of the nail fold that predispose individuals to chronic paronychia include psoriasis, mucocutaneous candidiasis, and drug toxicity from medications such as retinoids, epidermal growth factor receptor inhibitors (cetuximab), and protease inhibitors.1,2 Of particular interest is the antiretroviral drug indinavir, which induces retinoidlike effects and remains the most frequent cause of chronic paronychia in patients with HIV disease.
Fluctuant paronychia is usually caused by bacteria; therefore, routine Gram staining helps in identifying the organism.
Potassium hydroxide 5% smears may be helpful in diagnosing fluctuant paronychia if Gram staining results are negative or if candidal infection is suspected, as in chronic paronychia. If Gram staining results are positive, the KOH preparation may demonstrate pseudomycelia and clusters of grapelike yeast cells. KOH wet mounts from scrapings or discharge may show hyphae.
Tzanck smears may be performed if herpetic whitlow is suspected. Smears should be performed by using base scrapings of an unroofed vesicle. The presence of multinucleated giant cells, often with visible viral inclusions, indicates a positive result.
No radiologic studies are required. The diagnosis is primarily based on the features of the history and on the physical examination findings.
The treatment of choice depends on the extent of the infection. If diagnosed early, acute paronychia without obvious abscess can be treated nonsurgically. If an abscess has developed, incision and drainage must be performed. Surgical debridement may be required if fulminant infection is present.
Herpetic whitlow and paronychia must be distinguished because the treatments are drastically different. Misdiagnosis and mistreatment may do more harm than good. Once herpetic whitlow is ruled out, one must determine whether the paronychia is acute or chronic and then treat it accordingly.5
Acute paronychia
Warm water soaks of the affected finger 3-4 times per day until symptoms resolve are helpful.
Oral antibiotics with gram-positive coverage against S aureus, such as amoxicillin and clavulanic acid (Augmentin) or clindamycin (Cleocin), are usually administered concomitantly with warm water soaks. Cleocin and Augmentin also have anaerobic activity; therefore, they are useful in treating patients with paronychia due to oral anaerobes contracted through nail biting or finger sucking. Cleocin should be used instead of Augmentin in patients who are allergic to penicillin.
If the paronychia does not resolve or if it progresses to an abscess, it should be drained promptly.
Chronic paronychia
The initial treatment of chronic paronychia consists of the avoidance of inciting factors such as exposure to moist environments or skin irritants. Keeping the affected lesion dry is essential for proper recovery. Choice of footgear may also be considered.
Any manipulation of the nail, such as manicuring, finger sucking, or attempting to incise and drain the lesion, should be avoided; these manipulations may lead to secondary bacterial infections.
Mild cases of chronic paronychia may be treated with warm soaks.
The initial medical treatment consists of the application of topical antifungal agents. Topical miconazole may be used as the initial agent. Oral ketoconazole or fluconazole may be added in more severe cases.
Patients with diabetes and those who are immunocompromised need more aggressive treatment because the response to therapy is slower in these patients than in others.
In cases induced by retinoids or protease inhibitors, the paronychia usually resolves if the medication is discontinued.
If paronychia does not resolve despite best medical efforts, surgical intervention may be indicated. Also, if an abscess has developed, incision and drainage must be performed. Surgical debridement may be required if fulminant infection is present.
Acute paronychia
The no-incision technique is as follows:
The single- and double-incision techniques are as follows:
Chronic paronychia
Treatment is as follows: